Navigation Links
Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
Date:10/29/2008

- Study showed no consistent differences in bone mineral density at the lumbar spine and total hip between Advair Diskus 250/50 (fluticasone propionate and salmeterol inhalation powder) and salmeterol

- Study provides support for long term use of Advair(R) in patients with COPD

PHILADELPHIA, Oct. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that data from a three-year study of patients with Chronic Obstructive Pulmonary Disease (COPD) found that the inhaled corticosteroid in Advair Diskus 250/50, fluticasone propionate, did not show an adverse effect on bone mineral density (BMD) measured at the lumbar spine and total hip compared to salmeterol alone. In this study, designed to show equivalent rate of change in BMD for Advair and salmeterol, results for bone mineral density in the lumbar spine did not meet clinical equivalence although the rate of change favored Advair. The data was presented in Philadelphia at CHEST 2008, the annual meeting of the American College of Chest Physicians.

"These data are very encouraging for patients with COPD since most patients with this debilitating disease are at an age where they may also be at risk for bone loss," said Richard ZuWallack, MD of St. Francis Hospital and Medical Center, Hartford CT. "These data inform on the long-term impact of inhaled corticosteroids on bone mineral density."

About the Study

Effects of treatment with Advair Diskus 250/50 or salmeterol 50 mcg on BMD were evaluated in 186 patients (females and males 43 to 87 years of age) with COPD in a 3-year double-blind study. BMD evaluations were conducted at baseline and at 6-month intervals. The study was designed to show equivalence in the rate of change of BMD at the L1-L4 lumbar spine and total hip between Advair and salmeterol (defined as a difference in BMD of +/-1% per year). The difference in the rate of change of BMD for Advair versus salmeterol at the lumbar spine was +0.8% per year
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
2. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
3. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
4. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
5. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
6. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
7. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
8. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
9. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
10. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
11. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... N.Y. , Aug. 22, 2014  Mark ... tomography (CT) imaging facility, is using the online ... and even 5D imaging to researchers and would-be ... launched, asks "What would YOU do if you ... possibility to researchers and explorers everywhere, from elementary ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... Aug. 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ... today that it has completed integration with Nextech, ... Plastic Surgery and Dermatology practices. "Integration ... to healthcare practices using Nextech," stated Bob ... "Using information from the EMR we are able ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... 21, 2012 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH ... quarter ended December 31, 2011. Financial Results: ... ended December 31, 2011 were $28.4 million, as compared to ... 12 months ended December 31, 2011, total operating expenses were ...
... Link Platform:  BNVI.PK), a pharmaceutical company focused on the ... women,s health and cancer, today announced its decision to ... the Company has decided to delay the announcement of ... 2011, previously planned for today, to a later date.  ...
Cached Medicine Technology:Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 2Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 3Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 4Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 5Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update 6Bionovo Announces Decision to Explore Strategic Options and to Delay Announcement of Financial Results for 2011 2Bionovo Announces Decision to Explore Strategic Options and to Delay Announcement of Financial Results for 2011 3
(Date:8/22/2014)... Today, Zane Benefits, the #1 Online Health ... Plans. , According to Zane Benefits, employers are adopting ... the cost of healthcare without reducing coverage for employees. ... can be confusing. , The new guide contains a ... types of ABHPs. It also explains the similarities, ...
(Date:8/22/2014)... 22, 2014 MyWriters.com , an ... by marketing experts for marketers to help them drive ... the attention of Shane Michaels, prompting an investigative review. ... in any way knows that content is king when ... reports Michaels. “But even though content is extremely important, ...
(Date:8/22/2014)... Buying a policy for different life insurance ... about available coverage types by insurers in the U.S. The ... pricing to the public using its sortable tool at ... free and is expected to promote the discounts and special ... the U.S. The system is designed to help an adult ...
(Date:8/22/2014)... Worth, FL (PRWEB) August 22, 2014 Millennium ... of marijuana, resulting in a high level of drug use ... all ages fight against drug addiction and work to minimize ... highest levels of alcohol and drug addiction in history. According ... 2012, an estimated 23.9 million Americans aged 12 or older—or ...
(Date:8/22/2014)... By Amy Norton ... (HealthDay News) -- A growing number of Americans on ... a new study. Researchers found that between 2007 ... Security Disability Insurance benefits were prescribed narcotic painkillers each ... from 21 percent in 2007 to 23 percent in ...
Breaking Medicine News(10 mins):Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4
... the Escorts hospital here will soon get a Rs.300 million ... ,"We will invest Rs.30 crore (Rs.300 million) in Escorts within ... Monday. ,"Due to Dr. Naresh Trehan's focus on ... focus for the last 20 months. With Naresh no more ...
... anxious about their fertility can feel a bit relaxed now. ... fertility screening test, called Fertell. The test has his ... is the first at-home device to measure the concentration of ... hormone considered a marker of egg quality. ,The ...
... pregnant women can cause disorders in their children, says ... behavioural problems which are part of fetal alcohol spectrum ... lives of the individual and those around them. A ... conditions are completely preventable by not drinking any alcohol ...
... Abuse and Mental Health Services Administration (SAMHSA) today ... million over three years to the state ... Intervention Project. The first year award is $400,000. ... to early intervention and treatment services for youth ...
... revealed that stress boosts the production of a brain ... on mice has now shown that blocking a different ... reported online in the Proceedings of the National Academy ... Medicine in St. Louis, is among the first studies ...
... The International Myeloma Foundation (IMF)-supporting research and providing ... families, researchers and physicians-today said that data from ... clinical trial shows the combination of DOXIL(R) with ... ,The follow-up study also showed no ...
Cached Medicine News:Health News:Fortis to Inject Rs.300 Mn into Escorts Hospital 2Health News:Fertility Test at Home Possible With a New Kit 2Health News:Pregnancy and Alcohol - a Dangerous Cocktail Warns BMA Scotland 2Health News:Iowa to Receive Grant Funding for Youth Suicide Prevention, Early Intervention 2Health News:Stress Protein Inactivation Cuts Alzheimer's Peptide in Mice 2Health News:Velcade(R) Plus Doxil(R) Improves Previously Treated Multiple Myeloma Patients 2
HME w/bacterial viral filter w/CO2...
Indications For Usage: ,Infant (recommended tidal volume 20-70ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
Medicine Products: